In this study, the adiponectin/leptin ratio was lower in the BCRL group (0.28) than in the non-BCRL group (0.41), but the risk of MetS in both groups was equal given that both groups showed values below <0.5, which indicates severe MetS risk. The gene discussed is LEP; the disease is metabolic syndrome.